Shadowfax Technologies IPO
mainboardAlloted
GMP
₹0
mainboardAlloted
Shadowfax Technologies IPO
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹0
(-2.42%) Est. Gain
Investment Timeline
✓
IPO Open
20 Jan 2026
✓
IPO Close
22 Jan 2026
✓
Allotment
23 Jan 2026
✓
Listing
28 Jan 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
STRONG AVOID
29.7/100
🎯 Application Strategy
Action: 🚫 STRONG AVOID - Multiple red flags identified
Lots: DO NOT APPLY
⏳ Timing Advice
👍 Flexible timing - Apply by Day 3, good allotment chances
Key Factor Analysis
🚀
Demand
❌ Poor subscription levels - very weak investor interest
💰
Valuation
⚠️ Expensive valuation - limited room for gains
📈
Listing
❌ Risk of listing at discount or minimal gains
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹118.0 - ₹124.0
📦Lot Size
120 shares
💰Issue Size
₹1,907.27 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Shadowfax Technologies IPO?
As of today, the Grey Market Premium (GMP) for Shadowfax Technologies IPO is ₹0, which is approximately (-2.42%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Shadowfax Technologies IPO?
Our AI algorithm currently rates this IPO as "STRONG AVOID" with a score of 29.7/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Shadowfax Technologies IPO be announced?
The allotment status for Shadowfax Technologies IPO is expected to be finalized on 23 Jan 2026. Investors can check their status on the registrar's website.
What is the listing date for Shadowfax Technologies IPO?
Shares of Shadowfax Technologies IPO are proposed to be listed on stock exchanges on 28 Jan 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.